Framingham Heart Study Adds Proteomics, Pens CRADA with BG Medicine for Biomarker Discovery

The collaboration is the first cooperative research-and-development agreement between FHS and a commercial partner in the study's 60-year history. It also marks the first time the study has ever used proteomics.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.